Bictegravir/emtricitabine/tenofovir alafenamide as first-line treatment in naïve HIV patients in a rapid-initiation model of care: BIC-NOW clinical trial.
Tenorio CH, Sequera S, Vivancos MJ, Vinuesa D, Collado A, Santos IL, Sorni P, Cabello-Clotet N, Montero M, Font CR, Terron A, Galindo MJ, Martinez O, Ryan P, Omar-Mohamed M, Iglesias HA, Javier R, Ruz MÁ, Romero A, Vallecillos CG.
Tenorio CH, et al.
Int J Antimicrob Agents. 2024 Apr 2:107164. doi: 10.1016/j.ijantimicag.2024.107164. Online ahead of print.
Int J Antimicrob Agents. 2024.
PMID: 38574873
Free article.